Capricor $CAPR -68% after hours. FDA rejected deramiocel for Duchenne.
It was telegraphed:
- July: FDA panel voted 9-3 that the data didn't show efficacy
- FDA staff flagged that Capricor changed its analysis after the trial ended
I guess lesson is when the analysis plan moves after unblinding, so does your stock.
2
690
Merlin_Asset retweeted
Disappointing it took the media this many years to report this - plane loads of refugees were flown to Montreal for free, month after month, year after year, and put into mid-range hotels with free room service, free Internet, free nurses, free house-keeping. And health care.
FIRST READING: Free health care to refugee claimants now costing $2 million per day nationalpost.com/opinion/fir…
On the weekend the FDA rejected $SMMT drug. PFS win, but OS missed: HR 0.79, p=0.057. Not enough.
48 hours later Sellas $SLS hits OS outright in AML:
24.0 vs 14.7 months median survival
HR 0.59, p=0.035
The catch: 126 patients, 80 deaths. A small trial, but on the right endpoint.
The FDA just told everyone which endpoint it pays for. Sellas plans its BLA for 1H 2027
1
332
This must be the reason copper is rolling over. Clearly bringing on too much supply!
Britain's copper crime wave has become brazen and out of control, with thieves filming themselves slicing out cables all over the country to cash in on the precious metal inside.
@TomSkyNews investigates.
📺 trib.al/hO3OZDT
1
1
368
Merlin_Asset retweeted
Confirmed: he blew up, loaded up on calls hoping to make it all back quick, then blew up again.
Quebecor’s $QBR.B.TO offer is worth about C$19.45 per share, valuing Telus $T.TO at around C$31 billion ($21.7 billion). That would be a 60% premium to Friday’s closing share price.
216
CANACCORD $CF.TO ENTERS INTO AGREEMENT TO BE TAKEN PRIVATE BY CHAIRMAN AND CEO DAN DAVIAU
Shareholders to receive aggregate consideration of $15.27 per common share comprised of $7.45, plus proceeds of £4.15
Merlin_Asset retweeted
NP View: Carney’s expanded immigration plan is crashing our quality of life
nationalpost.com/opinion/np-…
Merlin_Asset retweeted
Ok let me get this straight:
- The most charismatic CEO in AI, who happens to be an open source proponent (which is obviously bad for Frontier models), gets ousted because of “surprise” leaks about his affair(s)
- Microsoft suffers a global outage, just a few days after Anthropic unveils an Office competitor
- just as Anthropic is about to IPO
… and none of you think this is weird at all?!!
The Golden Age of Rift ™️ is upon us
Altius Minerals to Acquire TNR Gold in C$122 Million Cash
The deal represents an implied consideration of about C$0.48 per TNR share, a 60% premium to the stock's closing price on Tuesday, which is listed on the TSX Venture Exchange
Congrats @YellowLabLife on surfacing the value.
Mirum $MIRM brelovitug in hepatitis delta. Second Phase 3 win in two months.
AZURE-4 at week 24:
300 mg weekly: 59% hit the combined endpoint
900 mg monthly: 44%
Delayed-treatment arm: 0%
The real story is the 108-week data in cirrhosis patients, with 100% virologic response and 100% ALT normalization (only 15 patients).
Half of these patients are cirrhotic and there's no approved HDV drug in the US. BLA is planned for H1 2027, and Vir is chasing the same market.
92
Merlin_Asset retweeted
For the first time in decades, America is about to start refining raw tin at scale. A first-of-its-kind plant in Henry County, Virginia, is set to begin production in 2027. A new deal secures its supply: up to 3,600 metric tons a year from the Democratic Republic of the Congo. Tin holds together the circuit boards in your phone, your car, and our defense systems. American workers will now smelt Congolese tin in the United States, creating jobs on both sides of the Atlantic. That is Pax Silica and the U.S.-DRC Strategic Partnership Agreement at work.
mining.com/alphamin-directs-…
Anthropic $ANT Retracts IPO Filing Details, Citing Inaccuracy: Rtrs
reuters.com/business/anthrop…
83


























